Skip to content
Screener

LB Pharmaceuticals Inc LBRX Current ratio

Current ratio at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
1.5×+0.3×
Alkermes logo
AlkermesALKS
2.3×-0.9×
MapLight Therapeutics, Inc. logo
MapLight Therapeutics, Inc.MPLT
22.9×—
Alto Neuroscience logo
Alto NeuroscienceANRO
20.5×-2.0×
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
3.4×+0.5×
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
21×+5.9×

Other financials

Income statement

See full
Net income-$19.1M-259%
EPS (diluted)-$0.67+95.5%

Balance sheet

See full
Cash & equivalents$320.7M—
Total debt$3.5M—
Total equity$378.7M+481%
Total assets$393.5M—

Cash flow

See full
Operating cash flow-$23.3M-187%
CapEx$32.0K+52.4%
Free cash flow-$23.3M-186%

Valuation

See full
Market cap$1.38B+309%
Enterprise value$1.06B—

Returns & leverage

See full
Return on equity-27.9%—
Debt / equity0×—

Where this comes from

Calculated from LB Pharmaceuticals Inc’s reported figures.

total current assets/total current liabilities=35.7×

Based on the most recent quarter.

The source filing: LB Pharmaceuticals Inc’s 10-Q, filed May 12, 2026. Open the filing →

Filed
May 12, 2026, 4:31 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-219607

FAQ

What is LB Pharmaceuticals Inc's current ratio?
LB Pharmaceuticals Inc (LBRX) reported current ratio of 35.7× in Q1 2026.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Ask your AI about LB Pharmaceuticals Inc's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude